1319196-67-2 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(2-bromo-3-methylphenyl)-3,4-dihydroisoquinoline is utilized as a key compound in the pharmaceutical industry for the research and development of new drugs. Its unique structure allows for the investigation of its interactions with various biological targets, which can lead to the discovery of novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(2-bromo-3-methylphenyl)-3,4-dihydroisoquinoline serves as an important tool for understanding the structure-activity relationships of different biological targets. This knowledge is crucial for the design and synthesis of new drugs with improved efficacy and selectivity.
Used in Organic Chemistry Research:
1-(2-bromo-3-methylphenyl)-3,4-dihydroisoquinoline is also employed in the study of organic chemistry, where its unique structure and properties can provide insights into various chemical reactions and mechanisms. This understanding can be applied to the development of new synthetic methods and the creation of novel chemical entities.
Used in Drug Discovery:
1-(2-bromo-3-methylphenyl)-3,4-dihydroisoquinoline holds potential in drug discovery due to its diverse pharmacological properties. Its unique structure can be exploited to design and develop new drugs targeting a range of diseases and conditions, making it a valuable asset in the search for novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1319196-67-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,9,1,9 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1319196-67:
(9*1)+(8*3)+(7*1)+(6*9)+(5*1)+(4*9)+(3*6)+(2*6)+(1*7)=172
172 % 10 = 2
So 1319196-67-2 is a valid CAS Registry Number.
1319196-67-2Relevant academic research and scientific papers
AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE
-
Page/Page column 37, (2011/08/08)
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein ring A, B1, B2, B3, L, R1, R2, ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).
